Cargando…
Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation
The K(V)7 potassium channel openers flupirtine and retigabine have been valuable options in the therapy of pain and epilepsy. However, as a result of adverse reactions, both drugs are currently no longer in therapeutic use. The flupirtine‐induced liver injury and the retigabine linked tissue discolo...
Autores principales: | Wurm, Konrad W., Bartz, Frieda‐Marie, Schulig, Lukas, Bodtke, Anja, Bednarski, Patrick J., Link, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541272/ https://www.ncbi.nlm.nih.gov/pubmed/35687532 http://dx.doi.org/10.1002/cmdc.202200262 |
Ejemplares similares
-
Modifications of the Triaminoaryl Metabophore of Flupirtine
and Retigabine Aimed at Avoiding Quinone Diimine Formation
por: Wurm, Konrad W., et al.
Publicado: (2022) -
Flupirtine Analogues: Explorative Synthesis and Influence of Chemical Structure on K(V)7.2/K(V)7.3 Channel Opening Activity
por: Surur, Abdrrahman S., et al.
Publicado: (2019) -
The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker
por: Su, Tzu-Rong, et al.
Publicado: (2012) -
Flupirtine: Clinical pharmacology
por: Harish, S, et al.
Publicado: (2012) -
Quinoidal Azaacenes: 99 % Diradical Character
por: Intorp, Sebastian N., et al.
Publicado: (2020)